A Comparative Study of Pulmonary Function Tests among Smokers and Non-Smokers in a Tertiary Care Hospital
Authors/Creators
- 1. Associate Professor, Department of Physiology, Aswini Rural Medical College and Hospital, Solapur
- 2. Associate Professor, Department of Physiology, Viswabharathi Medical College & General Hospital, Kurnool
Description
Background: Cigarette smoking has a significant impact on pulmonary function. Pulmonary function testing is a common procedure for diagnosing and monitoring respiratory disorders. In this study, the pulmonary function tests of smokers and nonsmokers were compared. Materials and Methods: Between January and June 2022, a case-control study was undertaken among smokers and nonsmokers. A total of 100 participants were recruited, 50 of whom were nonsmokers (controls) and 50 of whom were smokers (cases). PFT measurements were performed three times on each patient, with the greatest level recorded. Unpaired t test was used to analyse the data. Result: Pulmonary function parameters were significantly reduced in smokers and obstructive pulmonary impairment was commonest. The mean FVC, FEV1, FEV1/FVC, PEFR, FEF25%-75% in nonsmokers and smokers were 3.15±1.02, 2.62±0.92: 2.81±0.97, 2.17±0.75: 85.12±26.32, 82.13±21.85: 7.12±2.12, 5.86±1.98: 3.86±0.83, 3.12±1.21 respectively. Conclusion: Smokers had significantly lower lung function tests than nonsmokers, with obstructive pulmonary impairment being the most frequent. Thus, spirometry can detect a variety of lung problems at an early stage, reducing eventual morbidity.
Abstract (English)
Background: Cigarette smoking has a significant impact on pulmonary function. Pulmonary function testing is a common procedure for diagnosing and monitoring respiratory disorders. In this study, the pulmonary function tests of smokers and nonsmokers were compared. Materials and Methods: Between January and June 2022, a case-control study was undertaken among smokers and nonsmokers. A total of 100 participants were recruited, 50 of whom were nonsmokers (controls) and 50 of whom were smokers (cases). PFT measurements were performed three times on each patient, with the greatest level recorded. Unpaired t test was used to analyse the data. Result: Pulmonary function parameters were significantly reduced in smokers and obstructive pulmonary impairment was commonest. The mean FVC, FEV1, FEV1/FVC, PEFR, FEF25%-75% in nonsmokers and smokers were 3.15±1.02, 2.62±0.92: 2.81±0.97, 2.17±0.75: 85.12±26.32, 82.13±21.85: 7.12±2.12, 5.86±1.98: 3.86±0.83, 3.12±1.21 respectively. Conclusion: Smokers had significantly lower lung function tests than nonsmokers, with obstructive pulmonary impairment being the most frequent. Thus, spirometry can detect a variety of lung problems at an early stage, reducing eventual morbidity.
Files
IJPCR,Vol15,Issue2,Article60.pdf
Files
(282.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ccdfc383a741f88eb1c32823d09ae522
|
282.0 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-12-20
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue2,Article60.pdf
- Development Status
- Active
References
- 1. WHO Report: Tobacco Could Kill One Billion by 2100, Science Daily; Aug 2008; 24:71. 2. Yach D. Partnering for better lung health: Improving tobacco and tuberculosis control. Int J Tuberc Lung Dis 2000; 4: 693-7. 3. Tobacco could kill one billion by 2100: World Health Organization. Science daily 2008; 24:71. 4. Prasad BK, Sahay AP, Singh AK. Smoking women and their lung function test. Kathmandu Univ Med J (KUMJ) 2004; 2:142-4. 5. Jha P, Peto R. Global Effects of Smoking, of Quitting and of Taxing Tobacco. New England J Med. 2014; 370(1):60-8. 6. Anonymous. IUALTD; The World tobacco situation. IUALTD New Bull Tobacco Health 1998; 11: 19-21. 7. Armitage A. K, Turner, D. M. Absorption of nicotine in cigarette and cigar smoke through the oral mucosa. Nature. 1970;226: 1231 – 1232. 8. Tappel A. Auto Oxidant Nutrients. Executive health 1980; 16. 9. Fellows JL. Annual smoking attributable mortality, years life lost and economic costs United States, 2002; 51-300. 10. Capro JD. Respiratory structure and function. In: Goldman L, Bennett JC, (edi). Cecil textbook of medicine. 21st ed. Philadelphia: Saunders, 2000: p. 84-85. 11. Lin FL, Kelso JM. Pulmonary function studies in a healthy Filipinos adults residing in Unites States. J Allergy Clin Immunol 1999; 104:338-40. 12. Golshan M, Nemat-Bakhsh M. Normal prediction equations of Spirometric parameters in 799 healthy Iranian children and adolescents. Archives of Iranian medicine 2000; 3:109-13. 13. Burrows B, Khudson R.J, Martha Jeline, Lebowitz M.D. Quantitative relationship between cigarette smoking and ventilatory function. Amer. Review. Resp. Dis. 1977; Vol. 115, 195-205. 14. Pandya KD, Dadhani AC, Chandwani S. Effect of physical trainings, age, sex, posture and smoking o peak flowrates; In dianJ.Physiol&Pharmacol1984;28:3, 38. 15. Dhand R, Malik SK Sharma PK: Long term effects of tobacco smoking: Results of spirometric study in 300 old men. Ind. J. Chest Dis. And Allied Sci. 1985; Vol. 27: 44-49. 16. Gosavi G.R., Pisolkar R.M., Deshkar BV. Forced vital capacity in smokers and nonsmokers. Journal of Indian medical association. 1981; Vol. 77; 12; 189-191. 17. Gupta P, Dhir VS, Sharma K. Cardiorespiratory function in healthy smokers and nonsmokers. Ind. Jr. Physio. And Pharm. 1984; Vol. 28:5-30. 18. WHO; World tobacco epidemic; 1993; 2nd Edition; p-47.